No Photo Available

Last Update

2016-11-23T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Charles Saldarini?

Mr. Charles T. Saldarini

Founder and Chief Executive Officer

The Charles T. Saldarini Group

Direct Phone: (201) ***-****       

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

The Charles T. Saldarini Group

Background Information

Employment History

Carthage College

Vice Chairman and Chief Executive Officer

PDI , Inc.

Chief Executive Officer

Sentrx

Managing Partner

Votetocracy

Affiliations

Co-Founder
RELOVATE

Member Board of Directors
TrialScope Inc

Venture Advisor
Mid Atlantic Fund

Member Board of Directors
Rapid Pathogen Screening , Inc.

Board of Advisors
Anisfield School of Business at Ramapo College

Founding Board Member
CharityNavigator.com

Board Member
Cadient Group

Board Member
Syracuse University

Board Member, Independent Director
Informed Medical Communications Inc

Education

BA

Political Science and Communications Management

Syracuse University

Web References (99 Total References)


Latest Company Personnel News & Press Release - Free Company Personnel RSS Feed @ 1888 Press Release.com - page 13

www.1888pressrelease.com [cached]

Sentrx Announces Resignation of Charles T. Saldarini as CEO: Michael O'Gorman named CEO and Chairman of the Board

...
Sentrx, the leading provider of drug safety services to the life sciences industry, and the largest hosting provider of the Oracle Argus Safety Suite announced today that Charles T. Saldarini has resigned his position as CEO and Chairman of the Board to pursue efforts with his own company, The Charles T. Saldarini Group.


Structured Elements - Leadership

www.i-blink.com [cached]

Charles T. Saldarini

Charles T. Saldarini is the Founder/CEO of The Charles T. Saldarini Group, which evaluates both emerging and commercial stage companies in life sciences. ince 2006, he has been frequently engaged to provide strategic assessments for private equity investment, commercial product development and service company growth opportunities. e is an expert in biopharmaceutical services with substantial experience in product sales and marketing.
Prior to 2006, Saldarini spent 18 years with PDI (NASDAQ:PDII), where he was a major force in driving development of the contract sales industry.Saldarini led PDI from its earliest stage, built its reputation as a premier provider and drove its service revenue growth from ~$1M to $365M. hroughout his tenure, he oversaw creation of all infrastructure, systems and talent growth supporting an employee population of 3,000 and a world class client base.Saldarini's leadership enabled a successful public capitalization, as well as multiple acquisitions and strategic partnerships. t his departure as Vice Chairman and CEO in 2005, PDI was debt free, held over $100M in cash and was well positioned as a complete commercial services provider.


Board of Directors

www.rpsdetectors.com [cached]

Back row (standing - left to right): Charles Saldarini, Stephen La Neve, Caroline Popper

...
Charles T. Saldarini Director
Charles Saldarini is an expert in biopharmaceutical services and a proven leader across all phases of growth and turnaround. He is currently the Founder and CEO of The Charles T. Saldarini Group, where he provides strategic assessments for private equity investment, commercial product development, and growth opportunities for life science companies. Most recently, Saldarini served as head of Global Business Development for Octagon Clinical Research Solutions and as a member of the deal team that led the organization's sale to Accenture. Previously, he was CEO and Vice Chairman of Sentrx, where he successfully led a complete turnaround resulting in measurably higher quality, improved competitive position, and sustained profitability. Sentrx was recently acquired by TeleRx. Saldarini also led PDI, Inc., as CEO and Vice Chairman from its inception through peak service revenues of $365 million. In addition to RPS, Saldarini also serves on the Syracuse University Board of Visitors and his local Board of Education. Saldarini earned his BA in Political Science and Communications Management from Syracuse University.


Board of Directors

www.rpsdetectors.com [cached]

Back row (standing - left to right):Charles Saldarini,Stephen La Neve, Caroline Popper

...
Charles T. Saldarini Director
Charles Saldarini is an expert in biopharmaceutical services and a proven leader across all phases of growth and turnaround. He is currently the Founder and CEO of The Charles T. Saldarini Group, where he provides strategic assessments for private equity investment, commercial product development, and growth opportunities for life science companies. Most recently, Saldarini served as head of Global Business Development for Octagon Clinical Research Solutions and as a member of the deal team that led the organization's sale to Accenture. Previously, he was CEO and Vice Chairman of Sentrx, where he successfully led a complete turnaround resulting in measurably higher quality, improved competitive position, and sustained profitability. Sentrx was recently acquired by TeleRx. Saldarini also led PDI, Inc., as CEO and Vice Chairman from its inception through peak service revenues of $365 million. In addition to RPS, Saldarini also serves on the Syracuse University Board of Visitors and his local Board of Education. Saldarini earned his BA in Political Science and Communications Management from Syracuse University.


Board of Directors | TrialScope

www.trialscopeinc.com [cached]

Charles Saldarini Managing Partner, VoteTocracy Read More Read Less

Chuck is currently managing partner of VoteTocracy and a member of the Board of Directors at Rapid Pathogen Screening, Inc. Chuck is also the Founder and CEO of The Charles T. Saldarini Group, where he provides strategic assessments for private equity investment, commercial product development, and growth opportunities for life science companies. Most recently, Chuck served as head of Global Business Development for Octagon Clinical Research Solutions and as a member of the deal team that led the organization's sale to Accenture.
Previously, he was CEO and Vice Chairman of Sentrx, where he successfully led a complete turnaround resulting in measurably higher quality, improved competitive position, and sustained profitability. Sentrx was recently acquired by TeleRx. Chuck also led PDI, Inc., as CEO and Vice Chairman from its inception through peak service revenues of $365 million. In addition to RPS, Chuck also serves on the Syracuse University Board of Visitors and his local Board of Education. He earned his BA in Political Science and Communications Management from Syracuse University.

Similar Profiles

Other People with this Name

Other people with the name Saldarini

Giorgio Saldarini
ABB Ltd

Robert Saldarini
Bergen Community College

Davide Saldarini
Nespoli Group S.p.A

Daniel Saldarini
Green Mtn. Concert Services Inc

Kristen Saldarini
Bliss Integrated Communication

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory